Information  X 
Enter a valid email address

RenalytixAIPLC O0.25PRg S (RENX)

Related News

10-Jun-2022 11:21 AM

Renalytix says KidneyIntelX testing on patients shows clinical utility

Renalytix PLC on Friday said a recent testing at Mount Sinai Health System showed clinical utility and care benefits of KidneyIntelX. The London-based diagnostics company focused on kidney health said KidneyIntelX, a laboratory-developed test,
08-Apr-2022 04:01 PM

IN BRIEF: Renalytix raises $26.8 million through share subscription

Renalytix PLC - London-based diagnostics company focused on kidney health - Completes a $8.8 million equity subscription and a $21.2 million subscription for convertible bonds. Company raises $26.8 million as a result. Proceeds will be used
31-Mar-2022 01:14 PM

IN BRIEF: Renalytix jumps on increased revenue and financing package

Renalytix PLC - London-based diagnostics company focused on kidney health - Reports a widened pretax loss of $26.8 million for the six months to December 31, from $16.2 million a year before. Administrative expenses rise by 96% to $27.5 mil
09-Mar-2022 12:26 PM

Renalytix shares soar as it launches provider access portal myIntelX

Renalytix PLC shares soared on Wednesday after the company said it launched its new provider access portal myIntelX in the UK. Shares shot up 16% to 332.00 pence each on Wednesday morning in London. The London-based diagnostics company
19-May-2021 01:41 PM

Renalytix AI partners with three firms to advance kidney health

Renalytix AI, Atrium Health, Wake Forest Baptist Health and Wake Forest School of Medicine have announced a partnership to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure
22-Apr-2021 09:50 AM

Renalytix granted 10-year contract by US government

Renalytix AI plc has announced that the United States government has granted the company a 10-year Governmentwide Acquisition Contract (GWAC) to provide KidneyIntelX early-stage kidney disease bioprognostic? testing services. The contract, offered throu
26-Nov-2020 02:20 PM

EKF Diagnostics nets £5.6m from sale of stake in AI specialist

Healthcare company EKF Diagnostics has sold more than half of its stake in artificial intelligence-based diagnostics firm Renalytix AI. EKF sold nearly 1.7 million shares at £4.60 each, it announced this morning, raising just over £7.7 millio
06-Nov-2020 09:42 AM

Renalytix appoints joint corporate broker

Artificial intelligence-enabled in vitro diagnostics company Renalytix has announced it has appointed Investec Bank as joint corporate broker, with immediate effect. Investec will work alongside its existing nominated adviser and joint broker, Stifel. R
27-Oct-2020 09:13 AM

Renalytix AI losses deepen it develops kidney disease diagnostic product

Kidney disease diagnostics group Renalytix AI posted a deeper first-half loss as it continued to progress its flagship KidneyIntelX product towards commercialisation. Pre-tax losses for the year through June amounted to $10.6 million, compared to losses
03-Sep-2019 02:31 PM

Renalytix AI posts loss as it develops kidney disease diagnostic device

Kidney disease diagnostics group Renalytix AI posted a first-half loss as it continued to develop its flagship device. Pre-tax losses for the six months through June amounted to $6.5m, compared to losses of $0.4m posted from its inception through June, 2

a d v e r t i s e m e n t